This startup develops AI solutions for life sciences, specializing in drug discovery. Their technology designs, conducts, and troubleshoots tasks to accelerate new medication development.
Funding
Funding not disclosed
Founders
Product
Problem
The development of new medications is a complex, time-consuming, and expensive process, often facing bottlenecks in design, execution, and troubleshooting of experiments. Traditional drug discovery methods can be slow and inefficient, hindering the rapid advancement of life sciences research.
Solution
Kiin AI is developing an end-to-end AI Scientist platform designed to accelerate drug discovery. The platform aims to learn, design, execute, and troubleshoot complex scientific tasks involved in medication development. By automating and optimizing these processes, Kiin AI seeks to reduce the time and cost associated with bringing new drugs to market.
Target Audience
The primary target audience includes life science researchers and pharmaceutical companies involved in drug discovery and development.
Features
- AI-driven design of experiments for drug discovery
- Automated execution of scientific tasks
- AI-powered troubleshooting of experimental issues
- Machine learning models for optimizing drug development workflows